Skip to main content

Quantifying Hypoxia with Radiolabeled Fluoromisonidazole: Pre-Clinical and Clinical Studies

  • Chapter

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 33))

Abstract

The efforts to image hypoxia in oncology were stimulated by several questions about tumor biology and its role in response to treatment. What biochemical or physiological properties of tumors influence outcome of therapy? What drug or molecule is a natural substrate, precursor, or marker for the property of interest? Which characteristics of tumors are quantitatively, if not qualitatively different from normal tissues? Tumor hypoxia emerged as a feature that limits response to both radiation and chemotherapy and distinguishes tumors from nondiseased normal tissues, which are adequately oxygenated. It also appeared amenable to quantitation with PET imaging, provided one could develop an appropriate radiopharmaceutical that gave a positive image of oxygen-deprived tissue. A PET image of the metabolic rate of oxygen using [15O]O2 would produce a less desirable negative image for tissue with reduced oxygenation. Consideration of nonmalignant disease also identified two additional conditions where noninvasive quantification of oxygenation might be useful: myocardial infarct and cerebral ischemia.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Biskupiak, J. E., Grierson, J. R., Rasey, J. S., Martin, G. V., Krohn, K. A. Synthesis of an (Iodovinyl)misonidazole derivative for hypoxia imaging. J. Med. Chem. 34: 2165–2168, 1991.

    Article  PubMed  CAS  Google Scholar 

  • Blasberg, R., Horowitz, M., Strong, J., Molnar, P., Patlak, C., Owens, E., Fenstermacher, J. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors. Cancer Res. 45: 1692–1699, 1985.

    PubMed  CAS  Google Scholar 

  • Brizel, D. M., Rosner, G. L., Harrelson, J., Prosnitz, L. R., Dewhirst, M. W. Pretreatment oxygenation profiles of human soft tissue sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 30: 635–642, 1994.

    Article  PubMed  CAS  Google Scholar 

  • Caldwell, J. H., Revenaugh, J. R., Martin, G. V., Johnson, P. S., Grierson, J. R., Rasey, J. S., Krohn, K. A. A Comparison of 2-[18F]-Fluoro-2-deoxy-glucose (FDG) and [3H] fluoromisonidazole (FMISO) Uptake During Low -Flow Ischemia. J. Nucl. Med. 36: 1633–8, 1995.

    CAS  Google Scholar 

  • Casciari, J. J., Graham, M. M., Rasey, J. S. A modeling approach for quantifying tumor hypoxia with [F18]fluoromisonidazole PET time-activity data. Medical Physics 22: 1127–1139, 1995.

    Article  PubMed  CAS  Google Scholar 

  • Casciari, J. J., Rasey, J. S. Determination of radiobiologically hypoxic fraction in multicellular spheroids from [H-3]fluoromisonidazole uptake data. Radiat. Res. 141: 28–36, 1995.

    Article  PubMed  CAS  Google Scholar 

  • Chapman, J. D. Hypoxic sensitizers-implications for radiation therapy. N. Engl. J. Med. 301: 1429–1432, 1979.

    Google Scholar 

  • Chapman, J. D. The detection and measurement of hypoxic cells in solid tumors. Cancer 54: 2441–2449, 1984.

    Article  PubMed  CAS  Google Scholar 

  • Chapman, J. D., Franko, A. J., Sharplin, J. A marker for hypoxic cells in tumors with potential clinical applicability. Br. J. Cancer 43: 546–550, 1981.

    Article  PubMed  CAS  Google Scholar 

  • Franko, A. J. Misonidazole and other hypoxia markers: metabolism and applications. Int. J. Radiat. Oncol. Biol. Phys. 12: 1195–1202, 1986.

    Article  PubMed  CAS  Google Scholar 

  • Fyles, A., Milosevic, M., Kavanagh, M-C., Pintilie, M., Sun, A, Levin, W., Manchul, L., Keane, T.J., Hill, R. Hypoxia measured with a polarographic electrode correlates with radiation response in cervix cancer. Radiother. Oncol., submitted, 1996.

    Google Scholar 

  • Gatenby, R. A., Kessler, H. B., Rosenblum, J. S., Coia, L. R., Moldofsky, P. J., Hartz, W. H., Broder, G. J. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14 (5): 831–838, 1988.

    Article  CAS  Google Scholar 

  • Grierson, J. R., Link, J. M., Mathis, C. A., Rasey, J. S., Krohn, K. A. A radiosynthesis of fluorine-18 fluoromisonidazole. J. Nucl. Med. 30: 343–350, 1989.

    PubMed  CAS  Google Scholar 

  • Grunbaum, Z., Freauff, S. J., Krohn, K. A., Wilbur, D. S., Magee, S., Rasey, J. S. Synthesis and characterization of congeners of misonidazole for imaging hypoxia. J. Nucl. Med. 28: 68–75, 1987.

    CAS  Google Scholar 

  • Henk, J. M., Kunkler, P. B., Smith, C. W. Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial. Lancet 2 (8029): 101–103, 1977.

    Article  PubMed  CAS  Google Scholar 

  • Höckel, M., Knoop, C., Schlenger, K., Vorndran, B., Baußmann, E., Mitze, M., Knapstein, P. G., Vaupel, P. Intratumoral p02 predicts survival in advanced cancer of the uterine cervix. Radiother. Oncol. 26: 45–50, 1993.

    Article  PubMed  Google Scholar 

  • Höckel, M., Schlenger, K., Knoop, C., Vaupel, P. Oxygenation of carcinomas of the uterine cervix: evaluation by computered 02 tension measurements. Cancer Res. 51: 6098–6102, 1991.

    PubMed  Google Scholar 

  • Höckel, M., Vorndran, B., Schlenger, K., Baußmann, E., Knapstein, P. G. Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecologic Oncol. 51: 141–149, 1993.

    Article  Google Scholar 

  • Jerabek, P. A., Patrick, T. B., Kilbourn, M. R., Dischino, D. D., Welch, M. J. Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue. Int. J. Appl. Rad. Isotopes. 37: 599–605, 1986.

    CAS  Google Scholar 

  • Knox, R. J., Knight, R. C., Edwards, J. Studies on the action of nitroimidazole drugs. The products of nitroimidazoles in a radiolytic model system. Int. J. Radiat. Oncol. Biol. Phys. 10: 1323–1326, 1983.

    Google Scholar 

  • Koh, W-J., Bergman, K. S., Rasey, J. S., Peterson, L. M., Evans, M. L., Graham, M. M., Grierson, J. R., Lewellen, T. K., Krohn, K. A., Griffin, T. W. Evaluation of oxygenation status during fractionated radiotherapy in human non-small cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. Int. J. Radiat. Oncol. Biol. Phys., in press, 1996.

    Google Scholar 

  • Koh, W-J., Rasey, J. S., Evans, M. L., Grierson, J. R., Lewellen, T. K., Graham, M. M., Krohn, K. A., Griffin, T. W. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int. J. Radiat. Oncol. Biol. Phys. 22: 1–13, 1992.

    Article  Google Scholar 

  • Lartigau, E., Le Ridant, A-M., Lambin, P., Weeger, P., Martin, L., Sigal, R., Lusinchi, A., Luboinski, B., Eschwege, F., Guichard, M. Oxygenation of head and neck tumors. Cancer 71: 2319–2325, 1993.

    Article  PubMed  CAS  Google Scholar 

  • Martin, G. V., Biskupiak, J. E., Caldwell, J. H., Grierson, J. R., Krohn, K. A. Iodovinylmisonidazole: A metabolic marker for myocyte ischemia. J. Nucl. Med. 34: 918–924, 1993.

    PubMed  CAS  Google Scholar 

  • Martin, G.V., Caldwell, J. H., Graham, M. M, Grierson, J. R., Kroll, K, Cowan, M. J., Lewellen, T. K., Rasey, J. S., Casciari, J. J., Krohn, K. A. Noninvasive detection of hypoxic myocardium using 18Ffluoromisonidazole and positron emission tomography. J. Nucl. Med. 33: 2202–2208, 1992.

    PubMed  CAS  Google Scholar 

  • Martin, G. V., Cerqueira, M. D., Caldwell, J. H., Rasey, J. S., Embree, L., Krohn, K. A. Fluoromisonidazole: A metabolic marker of myocyte hypoxia. Circ. Res. 67: 240–244, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Martin, G. V., Rasey, J. S., Caldwell, J. C., Grunbaum, Z., Krohn, K. A. Fluoromisonidazole uptake in ischemic canine myocardium. J. Nucl. Med. 30: 194–201, 1989.

    PubMed  CAS  Google Scholar 

  • McClelland, R. A. Molecular interactions and biological effects of the products of reduction of nitroimidazoles. In: Adams, G.E., Breccia, A., Fiedlen, E.N., Wardman, P., eds. NATO Advanced Research Workshop on Selective Activation of Drugs by Redox Processes. New York, NY: Plenum Press, 125–136, 1990.

    Chapter  Google Scholar 

  • Moulder, J. E., Rockwell, S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int. J. Radiat. Oncol. Biol. Phys. 10: 695–712, 1984.

    Article  PubMed  CAS  Google Scholar 

  • Moulder, J. E., Rockwell, S. Tumor hypoxia: its impact on cancer therapy. Cancer Metast. Rev. 5: 313341, 1987.

    Google Scholar 

  • Overgaard, J., Sand-Hansen, H., Lindelov, B., Overgaard, M., Jorgensen, K., Rasmusson, B., Berthelsen, A. Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5–85, Radiother. Oncol. 20: 143–149, 1991.

    Google Scholar 

  • Raleigh, J. A., Koch, C. J. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochem. Pharm. 40: 2457–2464, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Rampling, R., Cruickshank, G., Lewis, A. D., Fitzsimmons, S. A., Workman, P. Direct measurement of pO2 distribution and bibreductive enzymes in human malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 29: 427–431, 1994.

    Article  CAS  Google Scholar 

  • Rasey, J. S., Evans, M. L. Detecting hypoxia in human tumors. In: Tumor Blood Supply and Metabolic Microenvironment: Characterizations and Implications for Therapy. P. Vaupel, R.K. Jain (Eds.). Funktionanalyse Biologischer Systeme 20, Gustav Fischer Verlag, 1991.

    Google Scholar 

  • Rasey, J. S., Grunbaum, Z., Magee, S., Nelson, N. J., Olive, P. L., Durand, R. E., Krohn, K. A. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. Radiat. Res. 111: 292–304, 1987.

    Article  PubMed  CAS  Google Scholar 

  • Rasey, J. S., Koh, W-J., Evans, M. L., Peterson, L. M., Lewellen, T. K., Graham, M. M., Krohn, K.A. Quantifying regional hypoxia in human tumors with positron emission tomography of [F18]fluoromisonidazole: A pretherapy study of 37 patients. Int. J. Rad. Oncol. Biol. Phys. 36: 417–428, 1996.

    Article  CAS  Google Scholar 

  • Rasey, J. S., Koh, W-J., Grierson, J. R., Grunbaum, Z., Krohn, K. A. Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia. Int. J. Rad. Oncol. Biol. Phys. 17 (5): 985–991, 1989.

    Article  CAS  Google Scholar 

  • Rasey, J. S., Nelson, N. J., Chin, L., Evans, M. L., Grunbaum, Z. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro. Radiat. Res. 122: 301–308, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Revenaugh, J. R., Caldwell, J. H., Martin, G. V., Grierson, J. L., Krohn, K. A. Positron emission tomography (PET) imaging of myocardial hypoxia with 18F-fluoromisonidazole (FMISO) in post myocardial infarction patients. Circulation 84 (íI): 424, 1991. [abstract]

    Article  Google Scholar 

  • Spence, A. M., Graham, M. M., Muzi, M., Abbott, G. L., Krohn, K. A., Kapoor, R., Woods, S. D. Deoxyglucose lumped constant estimated in a transplanted rat astrocytic glioma by the hexose utilization index. J. Cereb. Blood Flow Metab. 10: 190–198, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Van Putten, L. M., Kaltman, R. F. Oxygenation status of a transplantable tumor during fractionated radiation therapy. J. Natl. Cancer Inst. 40: 441–451, 1968.

    PubMed  Google Scholar 

  • Vaupel, P., Schlenger, K., Knoop, C., Höckel, M. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized 02 tension measurements. Cancer Res. 51: 3316–3322, 1991.

    PubMed  CAS  Google Scholar 

  • Whitmore, G.F., Varghese, A.J. The biological properties of reduced nitroheterocyclics and possible underlying biochemical mechanisms. Biochem. Pharm. 35: 97–103, 1986.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Rasey, J.S., Martin, G.V., Krohn, K.A. (1999). Quantifying Hypoxia with Radiolabeled Fluoromisonidazole: Pre-Clinical and Clinical Studies. In: Machulla, HJ. (eds) Imaging of Hypoxia. Developments in Nuclear Medicine, vol 33. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-1828-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-1828-8_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-5157-8

  • Online ISBN: 978-94-017-1828-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics